Learn more

THILO & CO GMBH DR

Overview
  • Total Patents
    19
About

THILO & CO GMBH DR has a total of 19 patent applications. Its first patent ever was published in 1977. It filed its patents most often in Germany and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and basic materials chemistry are FLOW PHARMA INC, XIA ERNING and GUO YONGDE.

Patent filings in countries

World map showing THILO & CO GMBH DRs patent filings in countries
# Country Total Patents
#1 Germany 14
#2 EPO (European Patent Office) 5

Patent filings per year

Chart showing THILO & CO GMBH DRs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Miestereck Helmut Dr Med 8
#2 Ploss Erich Dr Phil 5
#3 Kreiner Christine F Dr 4
#4 Runge Joachim Dr Phil 3
#5 Loebering Hans-Georg Dr Rer Na 3
#6 Tschoepe Michael Dr 2
#7 Scharrer Armin Dr 2
#8 Tschope Michael Dr 2
#9 Loebering Hans Georg Dr Rer Na 2
#10 Ober M Dr 1

Latest patents

Publication Filing date Title
EP0349735A2 Use of alkaline sorbic-acid salts in the sterilization of aqueous solutions of polyethylene oxide
DE3704823A1 CONTACT LENS CARE WITH DISINFECTING AND CLEANING EFFECT
DE3440352A1 Dry-eye packing
DE3339196A1 Antimicrobial preservative and disinfectant
DE3233638A1 DERMATOLOGICAL PREPARATION
DE3231584A1 Pharmaceutical solution for local administration
DE3102593A1 Pharmaceutical composition for use on the eye
DE3100478A1 5'ESTERS OF PYRIMIDINE NUCLEOSIDES WITH ANTIVIRAL EFFECTIVENESS, METHOD FOR THE PRODUCTION AND MEDICINAL PRODUCTS THEREOF
DE3033898A1 MEDICINES FOR LOCAL TREATMENT OF GLAUCOMA
DE3020129A1 Ophthalmic formulation for lowering excess internal eye pressure - contains a sotalol salt and surfactants e.g. benzalkonium chloride
DE2905033A1 Prolonged release medicament carrier esp. for ocular use - contg. physico-chemically modified polyvinyl alcohol, water, softening agents, and agents for isotonic regulation
DE2854279A1 Stabilised anti:glaucoma compsn. contg. pilocarpine - and pectin to reduce loss by hydrolysis
DE2854278A1 Compsn. for removing deposits from contact lenses - contains protease and nonionic wetting agent
DE2730201A1 PROSTAGLANDIN PROMOTERS
DE2729161A1 Analgesic and sedative medicaments - contg. 1,3-di:alkenyl-uracil derivs.